Future G-CSF concentration measurements for AML patients during consolidation cycles of D123 and D135 treatments and a comparison of our extended models with Quartino’s [30] integrated G-CSF-myelosuppression model or more sophisticated models from quantitative systems pharmacology [54] may shed light on these speculations. Here, CSF3 is linked to acute myeloid leukemia.